Time 7:30am – 2:00pm 1:00pm 1:00pm 2:00pm 3:30pm 3:30pm – 4:30pm 4:30pm6:00pm Wednesday October 15, 2014 Presentation Title/Event Board Meeting Registration Opens Exhibitor Set Up Begins PSHP Update and Healthcare Impact on Pharmacy Services Pharmacist Objectives: 1. Discuss the current topics pertaining to PSHP. 2. Identify and discuss the current healthcare environment and its effects on services that pharmacists provide. Technician Objectives: 1. Discuss the current topics pertaining to PSHP. 2. Discuss the impact that the current healthcare environment has on the duties and responsibilities of pharmacy technicians. Implementation of a Specialty Pharmacy Pharmacist Objectives: 1. What are important roles for Pharmacists within Specialty Pharmacy? Technician Objectives: 2. What are unique roles for Pharmacy Technicians within Specialty Pharmacy? Update of Antidiabetic Medications Pharmacist Objectives: 1. Review the major pathophysiologic defects in Type 2 Diabetes and targeted sites for medications 2. Describe the newer antidiabetic medication classes along with specific agents within the classes. Technician Objectives: Presenter CE Location BERKS ROOM Jennifer M. Belavic, PharmD, MBA, BCPS, FASCP 1.5 FOYER EVENT CENTER Monroe ROOM Richard Demers, MS, RPh, FASHP & Nishaminy Kasbekar, BS, PharmD, FASHP 1 Monroe ROOM Robert W. Rossi, RPh, CDE 1.5 Monroe ROOM 4:30pm6:00pm 6:00pm7:00pm 7:00pm8:00pm Technicians will recognize these newer agents in the course of carrying out their duties Reverse Trade Show EVENT CENTER Cocktail Reception with Exhibits Open EVENT CENTER Sponsored Product Theater Dinner Monroe Room TOTAL CE: 4 Time 7:00am 8:00am 8:00am 9:00am 9:00am – 10:00am Thursday October 16, 2014 Presentation Title/Event Novo Nordisk Sponsored Breakfast Presenter Scott Giberson, RPh, PhC, MPH, DSci (H) Rear Admiral, US Public Health Service, Acting US Deputy Surgeon General Chief Professional Offer, Pharmacy 1 EVENT CENTER/Buck Room Monroe ROOM Douglas Scheckelhoff, MS, FASHP 1 Monroe ROOM Deebeanne Tavani, DO, PhD Redefining the Use of Basal Insulin: Combining Sustained Action with QD Efficacy Moving Beyond the Tipping Point Pharmacist Objectives: 1. Discuss Pharmacy Report to the U.S. Surgeon General 2. Express transformative thinking based on current health system needs and pharmacy practice 3. Explain the importance of facilitating partnerships at the state level to help transform the profession 4. Explain a call-to-action that will improve the Nation’s health Technician Objectives: 1. Discuss Pharmacy Report to the U.S. Surgeon General 2. Express transformative thinking based on current health system needs and pharmacy practice 3. Explain the importance of facilitating partnerships at the state level to help transform the profession 4. Explain a call-to-action that will improve the Nation’s health Pharmacy Practice Advancement: How Far We’ve Come…What’s Coming Next Pharmacist Objectives: 1. Define practice model and how the Pharmacy Practice Model Initiative (PPMI) can help advance practice models in hospitals. 2. Identify key drivers of pharmacy practice change over the past 50 years. 3. Explain how the availability of qualified pharmacy technicians will play a pivotal role in enabling the advancement of pharmacist practice. 4. Describe the changes in adoption of automation and 10:00am 11:30am 11:30am 12:30pm 12:30pm 1:30pm 1:30pm2:30pm technology and how it creates new opportunities for pharmacy 5. Describe a how you can use the information presented to evaluate and advance practice of pharmacists and technicians in your setting practice setting Technician Objectives: 1. Define practice model and how the Pharmacy Practice Model Initiative (PPMI) can help advance practice models in hospitals. 2. Identify key drivers of pharmacy practice change over the past 50 years. 3. Explain how the availability of qualified pharmacy technicians will play a pivotal role in enabling the advancement of pharmacist practice 4. Describe the changes in adoption of automation and technology and how it creates new opportunities for pharmacy. 5. Describe a how you can use the information presented to evaluate and advance practice of pharmacists and technicians in your setting practice setting Exhibit Hall EVENT CENTER Lunch EVENT CENTER Considerations in Outsourcing Sterile Compounded Products Pharmacist Objectives: 1. Demonstrate an understanding of updated regulations regarding compounding pharmacies 2. Explain the considerations that should be evaluated when deciding to outsource compounded products Technician Objectives: 1. Recall the regulatory requirements necessary when outsourcing compounded sterile products 2. Describe the quality assurance requirements of an outsourced compounding pharmacy Advocacy for Pennsylvania Pharmacists Pharmacist Objectives: 1. List PSHP Advocacy Activities that have occurred 2. Describe your role in Advocacy or the legislative process Understand the importance of advocacy to the pharmacy community and public. Technician Objectives: 1. List PSHP Advocacy activities 2. Describe the process of a bill Matthew W. Eberts, PharmD, MBA, FASHP 1 Monroe ROOM Michele C. Musheno, MS, RPh 1 Monroe ROOM 2:30pm – 2:45pm 2:45pm – 4:45pm 3. Explain how to speak to your representative or Senator Break Current Topics in Hospital PharmacyPatient Safety Clinical Pearls Medication Safety Initiatives Pediatric Pharmacokinetic Pearls Evaluating the Quality of Dietary Supplements For Pain or Not for Pain: Methadone Madness Inhaled epoprostenol: Clinical and practical considerations Pharmacists as a Safety Measure in the Emergency Department Standardizing Compounded Pediatric and Neonatal Medications Pharmacist Objectives: 1. Discuss medication safety initiatives incorporated into practice at my institution 2. Identify barriers for implementation of safety initiatives 3. Review measures for success and data collection for safety initiatives 4. Review pharmacokinetic differences among the pediatric age categories. 5. Describe elements involved in pharmacogenetic influences on pharmacodynamics. 6. Describe the potential quality problems with the current dietary supplements on the market. 7. List examples of dietary supplement quality issues that have been reported by the FDA in the past year. 8. Discuss the various processes that can be used to evaluate the quality of dietary supplements. 9. Review one standard operating procedure for evaluating the quality of a dietary supplement. 10. Describe factors that make the Emergency Department one of the most dangerous places to receive healthcare 11. Illustrate how pharmacist presence in the ED setting can prevent medication errors 12. Using patient case examples, demonstrate medication safety events that can occur as a result of having multiple compounded drug concentrations 13. Describe safety initiatives aimed at standardization of compounded intravenous infusions and compounded oral liquids Technician Objectives: Clinical Pearls Laura Haynes, PharmD, BCPS Jenny Boucher, BS, PharmD, JD, BCPS Sarah C. Erush, PharmD, BCPS Maria Foy, PharmD, BCPS, CPE Peter Hlavinka, PharmD, BCPS Christopher Shaw, PharmD, BCPS Laura Hayn, PharmD, BCPS 2 Monroe ROOM 1. Discuss medication safety initiatives incorporated into practice at my institution 2. Identify barriers for implementation of safety initiatives 3. Review measures for success and data collection for safety initiatives 4. Show various parameters that are under consideration when making dosing decisions for pediatric patients of different ages Total CEs: 6 5:30pm – 7:00pm Time 7:00am – 8:00am 8:00am9:00am 9:00am 12:00pm 9:00am – 10:00am Awards Reception Friday October 17, 2014 Presentation Title/Event Breakfast Pain is Such a Pain (1 hour of patient safety CE) Pharmacist Objectives: 1. Review the scope of opioid related harm in hospitalized patients 2. Review regulatory recommendations and requirements for the appropriate use and monitoring of opioids in a hospitalized patient 3. Review types of diversion and methods to identify Technician Objectives: 1. Review some common look-alike sound-alike high risk errors that can occur in hospitalized patients. 2. Review potency differences of various high-risk opioids Student Leadership Development Workshop The Best of Times: Pharmacy in an Era of Accountable Care Pharmacist Objectives: 1. Describe the role of pharmacists in accountable care organizations (ACO) 2. List four key areas to address when developing an ambulatory care practice 3. Describe activities of a care transition pharmacist 4. List 3 resources to assist with planning pharmacy services in an ACO Technician Objectives: VISION BAR Presenter CE Charles J. Medico, PharmD, BCPS 1 Elaine Mebel Strauss, PharmD, MS Toni Fera, BS, PharmD Independent Healthcare Consultant 1 Location EVENT CENTER Monroe ROOM Foundry ROOM Monroe ROOM 10:00am – 10:30am 10:30am11:30am 11:30am – 12:30pm 1. Describe the role of pharmacists in accountable care organizations (ACO) 2. Describe activities of a care transition pharmacist 3. List 3 resources to assist with planning pharmacy services in an ACO Break Developments in the Treatment of Hepatitis C: A New Era Pharmacist Objectives: 1. Summarize the results of clinical trials for the newest medications approved for Hepatitis C treatment and where these medications fit into treatment decisions. 2. Discuss how to develop a clinical pharmacist program for the treatment of Hepatitis C and become an integral part of the treatment team. 3. Apply knowledge of the medication options for Hepatitis C to patient cases. Technician Objectives: 1. Summarize the results of clinical trials for the newest medications approved for Hepatitis C treatment and where these medications fit into treatment decisions. 2. Discuss how to develop a clinical pharmacist program for the treatment of Hepatitis C and become an integral part of the treatment team. 3. Apply knowledge of the medication options for hepatitis C to patient cases. Student and Resident Integration into Innovative Collaborative Pharmacy Practice Models Pharmacist Objectives: 1. Discuss how inter-professional education (IPE) learning experiences prepare graduates to develop meaningful partnerships and add value to your institution. 2. Describe opportunities for student and resident involvement in an interprofessional group medical visit practice model. 3. Describe resident and student involvement in the medication reconciliation and discharge processes at an urban, teaching medical center. 4. Identify opportunities for student and resident research involvement associated with the medication reconciliation and discharge processes. 5. Identify three opportunities to integrate student pharmacists Nancy Love, PharmD, BCPS 1 Monroe ROOM Jane Bowen, PharmD, BCPS Gladys Dueñas, PharmD, BCACP Valerie Ganetsky, PharmD, BCPS Anisha Grover, PharmD, BCACP Karleen Melody, PharmD, BCACP Sanchita Sen, PharmD, BCPS 1 Monroe ROOM and residents into a transitions of care (TOC) model that incorporates a community hospital and pharmacy. Technician Objectives: 1. Discuss how interprofessional education (IPE) learning experiences prepare graduates to develop meaningful partnerships and add value to your institution. 2. Describe opportunities for student and resident involvement in an interprofessional group medical visit practice model. 3. Describe resident and student involvement in the medication reconciliation and discharge processes at an urban, teaching medical center. 4. Identify opportunities for student and resident research involvement associated with the medication reconciliation and discharge processes. 5. Identify three opportunities to integrate student pharmacists and residents into a transitions of care (TOC) model that incorporates a community hospital and pharmacy. TOTAL CEs: 4 Total CEs if you attend the full conference: 14